3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Not yet recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
544
Triple Negative Breast Neoplasms
87
Neoplasms
19
Colorectal Neoplasms
19
Lung Neoplasms
16
Advanced Breast Cancer
16
Neoplasm Metastasis
15
Carcinoma, Non-Small-Cell Lung
15
Prostatic Neoplasms
14
Motor Activity
12
Breast Cancer Lymphedema
12
HER2-positive Breast Cancer
11
Uterine Cervical Neoplasms
10
Stomach Neoplasms
10
Ovarian Neoplasms
10
Carcinoma, Intraductal, Noninfiltrating
10
Anxiety Disorders
10
Endometrial Neoplasms
9
Depression
8
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Pain, Postoperative
6
Pain
6
Melanoma
6
Lymphedema
6
Head and Neck Neoplasms
6
Colonic Neoplasms
6
Cardiotoxicity
6
Sarcoma
5
Pancreatic Neoplasms
5
Interventions
trastuzumab deruxtecan
2
neratinib
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Breast Cancer With Brain Metastasis
×
Breast
×
Clear all
NCT07152782
2025-09-03
THUNDER
Fudan University
Phase 2
Not yet recruiting
202 enrolled
NCT07150208
2025-09-02
THUMB
Fudan University
Phase 2
Not yet recruiting
140 enrolled